{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T19:10:18Z","timestamp":1740165018224,"version":"3.37.3"},"reference-count":4,"publisher":"Medwave Estudios Limitada","issue":"06","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medwave"],"DOI":"10.5867\/medwave.2018.06.7300","type":"journal-article","created":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T13:07:58Z","timestamp":1540472878000},"page":"e7300-e7300","source":"Crossref","is-referenced-by-count":2,"title":["Anti-interleukin 5 therapy for chronic rhinosinusitis with polyps"],"prefix":"10.5867","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0112-9696","authenticated-orcid":false,"given":"Mar\u00eda Jos\u00e9","family":"Poblete","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6566-2169","authenticated-orcid":false,"given":"Andr\u00e9s","family":"Rosenbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5649-7058","authenticated-orcid":false,"given":"Mat\u00edas","family":"Winter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3888","published-online":{"date-parts":[[2018,10,25]]},"reference":[{"issue":"2","key":"ref0","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/all.13042","article-title":"Nasal and sinus symptoms and chronic rhinosinusitis in a population-based sample.","volume":"72","author":"Hirsch","year":"2017","unstructured":"Hirsch AG, Stewart WF, Sundaresan AS, Young AJ, Kennedy TL, Scott Greene J, Feng W, Tan BK, Schleimer RP, Kern RC, Lidder A, Schwartz BS. Nasal and sinus symptoms and chronic rhinosinusitis in a population-based sample. Allergy. 2017 Feb;72(2):274-281 | CrossRef | PubMed | PMC |","journal-title":"Allergy","ISSN":"https:\/\/id.crossref.org\/issn\/0105-4538","issn-type":"print"},{"issue":"1","key":"ref1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4193\/Rhin17.156","article-title":"Monoclonal antibodies for the treatment of chronic rhinosinusitis with nasal polyposis: a systematic review.","volume":"56","author":"Tsetsos","year":"2018","unstructured":"Tsetsos N, Goudakos JK, Daskalakis D, Konstantinidis I, Markou K. Monoclonal antibodies for the treatment of chronic rhinosinusitis with nasal polyposis: a systematic review. Rhinology. 2018 Mar 1;56(1):11-21. | CrossRef | PubMed |","journal-title":"Rhinology","ISSN":"https:\/\/id.crossref.org\/issn\/0300-0729","issn-type":"print"},{"issue":"9","key":"ref2","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1001\/jama.2015.7544","article-title":"Medical Therapies for Adult Chronic Sinusitis: A Systematic Review.","volume":"314","author":"Rudmik","year":"2015","unstructured":"Rudmik L, Soler ZM. Medical Therapies for Adult Chronic Sinusitis: A Systematic Review. JAMA. 2015 Sep 1;314(9):926-39. | PubMed |","journal-title":"JAMA","ISSN":"https:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"key":"ref3","unstructured":"Rivero A, Liang J. Anti-IgE and Anti-IL5 Biologic Therapy in the Treatment of Nasal Polyposis: A Systematic Review and Meta-analysis. Ann Otol Rhinol Laryngol. 2017 Nov;126(11):739-747. | CrossRef | PubMed | Bachert C, Sousa AR, Lund VJ, Scadding GK, Gevaert P, Nasser S, Durham SR, Cornet ME, Kariyawasam HH, Gilbert J, Austin D, Maxwell AC, Marshall RP, Fokkens WJ. Reduced need for surgery in severe nasal polyposis with mepolizumab: Randomized trial. J Allergy Clin Immunol. 2017 Oct;140(4):1024-1031.e14. | CrossRef | PubMed | Gevaert P, Lang-Loidolt D, Lackner A, Stammberger H, Staudinger H, Van Zele T, Holtappels G, Tavernier J, van Cauwenberge P, Bachert C. Nasal IL-5 levels determine the response to anti-IL-5 treatment in patients with nasal polyps. J Allergy Clin Immunol. 2006 Nov;118(5):1133-41. Epub 2006 Sep 26. | PubMed | Gevaert P, Van Bruaene N, Cattaert T, Van Steen K, Van Zele T, Acke F, De Ruyck N, Blomme K, Sousa AR, Marshall RP, Bachert C. Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis. J Allergy Clin Immunol. 2011 Nov;128(5):989-95.e1-8. | CrossRef | PubMed | Fokkens W, Lund V, Mullol J; European Position Paper on Rhinosinusitis and Nasal Polyps group. European position paper on rhinosinusitis and nasal polyps 2007. Rhinol Suppl. 2007;20:1-136. | PubMed | Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F, Cohen N, Cervin A, Douglas R, Gevaert P, Georgalas C, Goossens H, Harvey R, Hellings P, Hopkins C, Jones N, Joos G, Kalogjera L, Kern B, Kowalski M, Price D, Riechelmann H, Schlosser R, Senior B, Thomas M, Toskala E, Voegels R, Wang de Y, Wormald PJ. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology. 2012 Mar;50(1):1-12. | CrossRef | PubMed |"}],"container-title":["Medwave"],"original-title":[],"link":[{"URL":"https:\/\/www.medwave.cl\/link.cgi\/Medwave\/PuestaDia\/ResEpis\/7301","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T11:58:25Z","timestamp":1562846305000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.medwave.cl\/link.cgi\/Medwave\/PuestaDia\/ResEpis\/7301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,25]]},"references-count":4,"journal-issue":{"issue":"06","published-online":{"date-parts":[[2018,10,25]]}},"URL":"https:\/\/doi.org\/10.5867\/medwave.2018.06.7300","relation":{},"ISSN":["0717-6384"],"issn-type":[{"type":"electronic","value":"0717-6384"}],"subject":[],"published":{"date-parts":[[2018,10,25]]}}}